Welcome to Mesynthes

Unlocking Regenerative Healing

Mesynthes is a privately held regenerative medicine company applying its proprietary Endoform™ extracellular matrix (ECM) technology and biomaterials expertise to develop and commercialize products for wound and tissue repair.

In January 2010, we gained FDA 510k clearance for Endoform Dermal Template™ (EDT), our lead wound care product. We expect to launch EDT in the United States in 2011. We are also developing implantable regenerative tissue substitutes suitable for a wide range of soft tissue reinforcement and repair applications.

We work with leading surgeons, clinicians, nurses and researchers throughout the world to develop and commercialize innovations in regenerative medicine.

Transforming lives with regenerative healing...


Endoform's Advantage

Authentic Complexity™

+ Structure 
+ Substrates
+ Signals

RocketTheme Joomla Templates